Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Life Sciences Fund Amsterdam

Founders Harm de Vries Tom Schwarz

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 5
Rounds per year 0.47
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Medical Device
  • Medical
  • Health Care
  • Communities
Summary

In 2009 was created Life Sciences Fund Amsterdam, which is appeared as VC. The company was established in Europe in The Netherlands. The leading representative office of defined VC is situated in the Amsterdam.

Among the most popular fund investment industries, there are Communities, Medical Device. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight HiberCell, Neurent Medical.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Life Sciences Fund Amsterdam, startups are often financed by UvA Ventures Holding. The meaningful sponsors for the fund in investment in the same round are Western Development Commission, PPM Oost NV, Limburg Ventures. In the next rounds fund is usually obtained by PPM Oost NV, Holland Venture.

The fund was created by Harm de Vries, Tom Schwarz. The overall number of key employees were 2.

The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Life Sciences Fund Amsterdam:
Typical Co-investors
Life Sciences Fund Amsterdam is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Life Sciences Fund Amsterdam:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from The Netherlands
Funds with similar focus located in The Netherlands:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Advancesoft -
Chicago Board Options Exchange Chicago, Illinois, United States
Cornerstone Ventures Jeddah, Makkah, Saudi Arabia
Danish Maritime Fund -
FbStart California, Menlo Park, United States
firedUP Columbia, South Carolina, United States
Goldcrest Capital Dallas, Texas, United States
Guoke Zhengdao Investment Beijing, Beijing, China
Intuit Prosperity Accelerator -
Lincolnshire Management New York, New York, United States
Medical Technology Venture Partners California, San Francisco, United States
Miller Johnson Steichen Kinnard Inc Minneapolis, Minnesota, United States
P Management 415 Inc. -
P3 Invest Zrt Budapest, Hungary
Presbyterian Health Foundation Oklahoma, Oklahoma City, United States
Prime Ventures Amsterdam, Noord-Holland, The Netherlands
Stonehammer Capital -
Two Shields Investments England, United Kingdom, Wandsworth
Vanguard Atlantic New York, Saranac Lake, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

HiberCell

Biotechnology
Health Care
Health Diagnostics
Medical
$60M07 Feb 2019 New York, United States

Neurent Medical

Biotechnology
Health Care
Medical
Medical Device
Surgical Devices
Therapeutic Devices
$11M28 May 2018 Ireland, County Galway, Ireland

Sigmascreening

Biotechnology
Communities
Medical Device
06 Oct 2010 Amsterdam, North Holland, Netherlands

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Life Sciences Fund Amsterdam?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 11M
Rounds per year 0.47
Peak activity year 2018
Lead investments 1
Follow on index 0.29
Group Appearance index 0.71

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

HiberCell

Biotechnology
Health Care
Health Diagnostics
Medical
$60M07 Feb 2019 New York, United States

Neurent Medical

Biotechnology
Health Care
Medical
Medical Device
Surgical Devices
Therapeutic Devices
$11M28 May 2018 Ireland, County Galway, Ireland

Sigmascreening

Biotechnology
Communities
Medical Device
06 Oct 2010 Amsterdam, North Holland, Netherlands
Crunchbase icon

Content report

The following text will be sent to our editors: